Evidence map›Paper›PMID 30301902›Full record

ArticleScientific reports2018

Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study.

Suresh Mehata, Nipun Shrestha, Ranju Kumari Mehta, Bihungum Bista, Achyut Raj Pandey, Shiva Raj Mishra

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Prevalence of the Metabolic Syndrome Among Batswana Adults in Urban and Semi-Urban Gaborone.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  18. Article
  19. Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suresh MehataIpas Nepal, Kathmandu, 44600, Nepal. sureshmht@gmail.com.
Nipun ShresthaInstitute for Health and Sport (IHES), Victoria University, Melbourne, 1300 VIC UNI, Australia.ORCID http://orcid.org/0000-0003-3542-8130
Ranju Kumari MehtaNepal Health Research Council, Ministry of Health and Population, Kathmandu, 44600, Nepal.
Bihungum BistaNepal Health Research Council, Ministry of Health and Population, Kathmandu, 44600, Nepal.
Achyut Raj PandeyNepal Health Research Council, Ministry of Health and Population, Kathmandu, 44600, Nepal.
Shiva Raj MishraNepal Development Society, Chitwan, 44207, Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) increases the risk of cardiovascular diseases and diabetes mellitus. This study is designed to assess the prevalence and determinants of MetS among Nepalese adults from a nationally representative study. This study is based on Stepwise Approach to Surveillance (STEPS) Survey from Nepal. This survey was done among 4200 adults aged 15-69 years from 210 clusters selected proportionately across Nepal's three ecological zones (Mountain, Hill and Terai). Subsequently, using systematic sampling, twenty households per cluster and one participant per household were selected. The overall prevalence of MetS is 15% and 16% according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria respectively. A triad of low HDL-C, abdominal obesity and high BP was the most prevalent (8.18%), followed by abdominal obesity, low HDL-C cholesterol and high triglycerides (8%). Less than two percent of participants had all the five components of the syndrome and 19% of participants had none. The prevalence steadily rose across the age group with adults aged 45-69 years having the highest prevalence (28-30%) and comparable prevalence across two definitions of MetS. A notably high burden for females, urban, hill or Terai resident were seen among other factors.

Indexed as

AdolescentAdultAgedCardiovascular DiseasesCholesterol, HDLCross-Sectional StudiesDiabetes MellitusFemaleHumansMaleMetabolic SyndromeMiddle AgedNepalObesity, AbdominalRisk FactorsTriglyceridesCholesterol, HDLTriglycerides

Identifiers

PMID30301902
PMCPMC6177417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.